Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 06-Oct-23 5:56 PM View:  | Acelyrin, Inc. (SLRN) | 04-Oct-23 | Acquisition (other) | 14,675 | -- | -- | 100% 0 to 14.68K | |
| 16-Jun-22 4:26 PM View: | Arcus Biosciences, Inc. (RCUS) | 14-Jun-22 | Grant | 4,100 | -- | -- | 68% 6.0K to 10.1K | |
| 07-Jun-21 4:40 PM View: | Arcus Biosciences, Inc. (RCUS) | 03-Jun-21 | Grant | 3,000 | -- | -- | 100% 3.0K to 6.0K | |
| 24-Mar-21 7:46 PM View: | Adverum Biotechnologies, Inc. (ADVM) | 24-Mar-21 | Market Purchase | 10,000 | $9.92 | $99,196.00 | 13% 78.18K to 88.18K | (< 1%) |
| 19-Jan-21 8:33 PM View: | Adverum Biotechnologies, Inc. (ADVM) | 15-Jan-21 | Market Purchase | 10,000 | $11.52 | $115,174.00 | 15% 68.18K to 78.18K | (1%) |
| 08-Jun-20 4:32 PM View: | Arcus Biosciences, Inc. (RCUS) | 04-Jun-20 | Grant | 3,000 | -- | -- | 100% 0 to 3.0K | |
| 19-Jun-19 6:30 PM View: | Urovant Sciences Ltd. (UROV) | 19-Jun-19 | Market Purchase (Planned) Duplicate | 4,957 | $8.17 | $40,495.20 | < 1% 22.86M to 22.86M | 99% |
| 19-Jun-19 6:30 PM View: | Urovant Sciences Ltd. (UROV) | 18-Jun-19 | Market Purchase (Planned) Duplicate | 6,706 | $8.21 | $55,061.00 | < 1% 22.85M to 22.86M | 98% |
| 19-Jun-19 6:30 PM View: | Urovant Sciences Ltd. (UROV) | 17-Jun-19 | Market Purchase (Planned) Duplicate | 6,541 | $8.53 | $55,824.80 | < 1% 22.84M to 22.85M | 90% |
| 14-Jun-19 6:15 PM View: | Urovant Sciences Ltd. (UROV) | 14-Jun-19 | Market Purchase (Planned) Duplicate | 7,144 | $7.91 | $56,514.00 | < 1% 22.83M to 22.84M | 105% |
| 14-Jun-19 6:15 PM View: | Urovant Sciences Ltd. (UROV) | 13-Jun-19 | Market Purchase (Planned) Duplicate | 7,367 | $7.95 | $58,542.60 | < 1% 22.83M to 22.83M | 104% |
| 14-Jun-19 6:15 PM View: | Urovant Sciences Ltd. (UROV) | 12-Jun-19 | Market Purchase (Planned) Duplicate | 7,500 | $8.30 | $62,244.00 | < 1% 22.82M to 22.83M | 95% |
| 11-Jun-19 6:31 PM View: | Urovant Sciences Ltd. (UROV) | 11-Jun-19 | Market Purchase (Planned) Duplicate | 7,189 | $8.58 | $61,693.80 | < 1% 22.81M to 22.82M | 89% |
| 11-Jun-19 6:31 PM View: | Urovant Sciences Ltd. (UROV) | 10-Jun-19 | Market Purchase (Planned) Duplicate | 7,500 | $8.35 | $62,594.20 | < 1% 22.81M to 22.81M | 94% |
| 11-Jun-19 6:31 PM View: | Urovant Sciences Ltd. (UROV) | 07-Jun-19 | Market Purchase (Planned) Duplicate | 6,649 | $7.97 | $52,959.30 | < 1% 22.8M to 22.81M | 104% |
| 06-Jun-19 6:01 PM View: | Urovant Sciences Ltd. (UROV) | 06-Jun-19 | Market Purchase (Planned) Duplicate | 7,082 | $8.00 | $56,621.30 | < 1% 22.79M to 22.8M | 103% |
| 06-Jun-19 6:01 PM View: | Urovant Sciences Ltd. (UROV) | 05-Jun-19 | Market Purchase (Planned) Duplicate | 6,540 | $8.02 | $52,418.10 | < 1% 22.78M to 22.79M | 102% |
| 06-Jun-19 6:30 PM View: | Myovant Sciences Ltd. (MYOV) | 04-Jun-19 | Private Purchase Duplicate | 2,424,240 | $8.25 | $20,000,000.00 | 6% 38.34M to 40.77M | |
| 06-Jun-19 6:01 PM View: | Urovant Sciences Ltd. (UROV) | 04-Jun-19 | Market Purchase (Planned) Duplicate | 7,500 | $7.59 | $56,910.80 | < 1% 22.78M to 22.78M | 114% |
| 03-Jun-19 7:17 PM View: | Urovant Sciences Ltd. (UROV) | 03-Jun-19 | Market Purchase (Planned) Duplicate | 5,424 | $7.71 | $41,814.70 | < 1% 22.77M to 22.78M | 110% |
| 03-Jun-19 7:17 PM View: | Urovant Sciences Ltd. (UROV) | 31-May-19 | Market Purchase (Planned) Duplicate | 5,071 | $7.70 | $39,042.10 | < 1% 22.77M to 22.77M | 111% |
| 03-Jun-19 7:17 PM View: | Urovant Sciences Ltd. (UROV) | 30-May-19 | Market Purchase (Planned) Duplicate | 7,251 | $8.01 | $58,089.50 | < 1% 22.76M to 22.77M | 102% |
| 29-May-19 6:33 PM View: | Urovant Sciences Ltd. (UROV) | 29-May-19 | Market Purchase (Planned) Duplicate | 6,882 | $7.55 | $51,983.20 | < 1% 22.75M to 22.76M | 115% |
| 29-May-19 6:33 PM View: | Urovant Sciences Ltd. (UROV) | 28-May-19 | Market Purchase (Planned) Duplicate | 3,807 | $7.68 | $29,244.60 | < 1% 22.75M to 22.75M | 111% |
| 29-May-19 6:33 PM View: | Urovant Sciences Ltd. (UROV) | 24-May-19 | Market Purchase (Planned) Duplicate | 3,796 | $7.70 | $29,233.40 | < 1% 22.75M to 22.75M | 111% |
| 23-May-19 6:30 PM View: | Urovant Sciences Ltd. (UROV) | 23-May-19 | Market Purchase (Planned) Duplicate | 4,802 | $7.76 | $37,252.00 | < 1% 22.74M to 22.75M | 109% |
| 23-May-19 6:30 PM View: | Urovant Sciences Ltd. (UROV) | 22-May-19 | Market Purchase (Planned) Duplicate | 5,033 | $8.06 | $40,557.90 | < 1% 22.74M to 22.74M | 101% |
| 23-May-19 6:30 PM View: | Urovant Sciences Ltd. (UROV) | 21-May-19 | Market Purchase Duplicate | 9,995 | $8.52 | $85,108.40 | < 1% 22.73M to 22.74M | 90% |
| 20-May-19 6:30 PM View: | Urovant Sciences Ltd. (UROV) | 20-May-19 | Market Purchase Duplicate | 10,000 | $8.05 | $80,524.80 | < 1% 22.72M to 22.73M | 101% |
| 20-May-19 6:30 PM View: | Urovant Sciences Ltd. (UROV) | 17-May-19 | Market Purchase Duplicate | 6,200 | $7.36 | $45,641.30 | < 1% 22.71M to 22.72M | 120% |
| 20-May-19 6:30 PM View: | Urovant Sciences Ltd. (UROV) | 16-May-19 | Market Purchase Duplicate | 5,408 | $6.79 | $36,718.20 | < 1% 22.7M to 22.71M | 139% |
| 19-Mar-19 5:03 PM View: | Sio Gene Therapies Inc. (SIOX) | 18-Mar-19 | Market Purchase Duplicate | 6,666,670 | $1.50 | $10,000,000.00 | 7% 99.29M to 105.95M | (72%) |
| 21-Dec-18 12:54 PM View: | Endocyte, Inc. (ECYT) | 21-Dec-18 | Disposition | 7,050 | $24.00 | $169,200.00 | (100%) 7.05K to 0 | < 1% |
| 20-Dec-18 6:03 AM View: | Sio Gene Therapies Inc. (SIOX) | 18-Dec-18 | Market Purchase Duplicate | 10,000,000 | $1.00 | $10,000,000.00 | 11% 89.29M to 99.29M | (58%) |
| 03-Oct-18 4:49 PM View: | Urovant Sciences Ltd. (UROV) | 01-Oct-18 | Purchase Duplicate | 2,678,570 | $14.00 | $37,500,000.00 | 13% 20.03M to 22.7M | |
| 07-Jun-18 7:32 AM View: | Sio Gene Therapies Inc. (SIOX) | 05-Jun-18 | Market Purchase Duplicate | 14,285,700 | $1.75 | $25,000,000.00 | 19% 75.0M to 89.29M | (76%) |
| 04-May-18 5:03 PM View: | Endocyte, Inc. (ECYT) | 03-May-18 | Grant | 3,300 | -- | -- | 88% 3.75K to 7.05K | |
| 04-Apr-18 4:51 PM View: | Myovant Sciences Ltd. (MYOV) | 02-Apr-18 | Market Purchase Duplicate | 1,110,020 | $20.27 | $22,500,000.00 | 3% 37.23M to 38.34M | 5% |
| 01-Mar-18 3:14 PM View: | Endocyte, Inc. (ECYT) | 27-Feb-18 | Grant | 3,750 | -- | -- | 100% 0 to 3.75K | |
| 14-Jun-17 7:04 PM View: | Adverum Biotechnologies, Inc. (ADVM) | 12-Jun-17 | Grant | 22,727 | -- | -- | 50% 45.45K to 68.18K | |
| 16-Mar-17 7:19 PM View: | Adverum Biotechnologies, Inc. (ADVM) | 14-Mar-17 | Grant | 45,455 | -- | -- | 100% 0 to 45.45K | |
| 30-Sep-16 5:51 PM View: | Medivation, Inc. (MDVN) | 28-Sep-16 | Disposition (change in control) | 70,792 | -- | -- | (100%) 70.79K to 0 | |
| 16-Sep-16 8:50 AM View: | SCYNEXIS, Inc. (SCYX) | 15-Sep-16 | Market Purchase | 40,000 | $2.94 | $117,600.00 | 200% 20.0K to 60.0K | (80%) |
| 28-Jun-16 7:53 AM View: | SCYNEXIS, Inc. (SCYX) | 24-Jun-16 | Market Purchase | 20,000 | $2.39 | $47,800.00 | 100% 0 to 20.0K | (76%) |
| 23-Jun-16 8:41 PM View: | Medivation, Inc. (MDVN) | 22-Jun-16 | Grant | 2,972 | -- | -- | 4% 67.82K to 70.79K | |
| 21-Jan-16 5:45 PM View: | Medivation, Inc. (MDVN) | 19-Jan-16 | Option Exercise | 75,000 | $3.37 | $252,525.00 | 113% 66.16K to 141.16K | |
| 21-Jan-16 5:45 PM View: | Medivation, Inc. (MDVN) | 19-Jan-16 | Market Option Sale (Planned) | 75,000 | $37.34 | $2,800,560.00 | (53%) 141.16K to 66.16K | (118%) |
| 30-Dec-15 2:33 PM View: | Chimerix, Inc. (CMRX) | 29-Dec-15 | Market Purchase | 10,000 | $7.08 | $70,846.00 | 100% 0 to 10.0K | 11% |
| 28-Sep-15 7:14 PM View: | Medivation, Inc. (MDVN) | 25-Sep-15 | Option Exercise | 71,980 | $4.69 | $337,766.00 | 109% 66.16K to 138.14K | |
| 28-Sep-15 7:14 PM View: | Medivation, Inc. (MDVN) | 25-Sep-15 | Market Option Sale (Planned) | 71,980 | $42.36 | $3,049,110.00 | (52%) 138.14K to 66.16K | (92%) |